KAMALESH RAO – Founder and Chief Executive Officer
- Natural products chemist by training
- 20+ years experience in Drug development, Implant development, and Product approvals.
- Played a pivotal role in the development of Probuphine®, an implant able formulation approved by the USFDA to treat opioid addiction.
DR. SADHANA SATHAYE – Chief Scientific Officer
- Professor of Pharmacology at Institute Of Chemical Technology
- Ph.D. (Tech), Pharmacology
- Research in Epilepsy, Parkinson’s and Alzheimer’s
- Expert in pharmacokinetics and pharmacodynamics modeling
- Authored 75 research publications
DR. VIDYA HEBBAR – Vice President, Product Development
- Pharmacist Reg. in NY, CA and MD
- Ph.D., Pharmaceutical Sciences, Univ. of Oklahoma
- Research in the area of signal transduction mechanisms of cancer-chemo preventive agents
DEEPAK PINGALAY – Chief Operations Officer
- Business Operations and Marketing Executive with focus on GTM, Scale and Growth Strategies and Partnerships Ecosystem Development
- M.S. in Materials Science & Engineering
- Serial Entrepreneur and Management Consultant.
DR. PURNIMA AMIN – Technology Consultant
- Professor of Pharmacy at Institute Of Chemical Technology
- Ph.D. (Tech), Pharmacy
- Recognized industry expert in Hot Melt Extrusion (HME), solid dosage forms, and bioavailability enhancement
JEREMIAH F O’LEARY – Chief Financial Officer
- CPA and ex-JP Morgan Leader
- Board Member / Adviser for several organizations
DR. USHA NAYAK – Technology Advisor
- Faculty at Manipal College of Pharmaceutical Sciences
- PhD in Pharmaceutics
- Expert in nano-pharmaceuticals, controlled drug delivery, and bioavailability enhancement
JOHNO’LEARY – Chief Legal Officer
- General Counsel
- Expert in securities laws, private to public, and compliance.